Intel stock slips in premarket after KeyBanc’s “sold out” call sets up next week’s earnings

Intel stock slips in premarket after KeyBanc’s “sold out” call sets up next week’s earnings

New York, Jan 15, 2026, 08:53 (EST) — Premarket

  • Intel shares edged lower before the open after a sharp two-day rally tied to a bullish analyst upgrade
  • KeyBanc flagged tight 2026 server CPU supply and possible price hikes, lifting its target to $60
  • Investors now look to Intel’s Jan. 22 results for proof the demand story is showing up in numbers

Intel shares were down about 0.5% in premarket trading on Thursday at $48.48, after rising 3% in the prior session to close at $48.72. (MarketWatch)

The stock’s latest run followed a KeyBanc Capital Markets upgrade to “overweight,” alongside a $60 price target, arguing demand tied to artificial intelligence data centers has tightened supply for next year. Intel jumped nearly 9% on Tuesday after the note, with Advanced Micro Devices also climbing. (Investopedia)

KeyBanc analyst John Vinh said Intel was “largely sold out” in server central processing units (CPUs) for 2026, and called “outsized” demand from hyperscalers — the biggest cloud firms — a “significant tailwind” for data center revenue. (A CPU is the main processor that runs a server.) (TipRanks)

Trading in Intel was heavy on Wednesday. About 147 million shares changed hands, roughly 60% above its three-month average, as the stock stayed near recent highs. (Nasdaq)

Semiconductor sentiment was also helped by Taiwan Semiconductor Manufacturing Co, which jumped about 6% in premarket trading after strong quarterly results tied to AI chip demand, lifting parts of the sector. (Investors)

Intel’s story is still a work-in-progress. The company is trying to steady its core PC and data center business while building a foundry — contract chipmaking — arm that would make chips for outside customers.

The “sold out” line is not a clean win, though. If supply is tight, Intel may not be able to ship enough to fully meet demand, and higher prices can push customers to rivals, including AMD.

There is also a timing risk. The rally has pulled a lot of optimism forward, and any wobble in guidance or a softer read on data center orders can hit a stock that has moved fast in a few sessions.

Broader markets were choppy on Wednesday, with the main U.S. indexes sliding as bank earnings and high-priced tech weighed on sentiment. (AP News)

The next hard catalyst is Intel’s quarterly report on Jan. 22, after the close, followed by an earnings call at 2 p.m. PT. (Intel Corporation)

Stock Market Today

  • Merck's 32% Rally Fails to Alter Bearish View, Keytruda Remains Key Driver
    January 15, 2026, 10:17 AM EST. Merck's stock has jumped about 32% in three months, trading above its 50-day and 200-day SMA since November. Still, the rally hasn't altered the bear case. Keytruda remains the linchpin, accounting for more than half of pharmaceutical sales and posting $23.3 billion in the first nine months of 2025, up 8%. Growth comes from early-stage NSCLC uptake and ongoing metastatic indications. Merck is pushing immuno-oncology combinations and has a subcutaneous Keytruda Qlex that extends protection beyond 2028. The company's pipeline has expanded to roughly 20 upcoming launches, aided by M&A, with Capvaxive and Winrevair cited as long-term bets. Other oncology drugs like Welireg, Lynparza and Lenvima support near-term topline. Risks include patent cliffs and the need for durable new catalysts.
Ondas Holdings (ONDS) stock slips premarket as investors weigh $1B raise and Friday’s Investor Day
Previous Story

Ondas Holdings (ONDS) stock slips premarket as investors weigh $1B raise and Friday’s Investor Day

Go toTop